
Share of consumption of biosimilar drugs in Italy 2016-2022
Between 2016 and 2022, the share of biosimilars consumed out of the total marketed molecules for which the biosimilar variation was available, increased from 13 to 48 percent. Biosimilars are drugs of biological origin which are very similar in function and effect to previously approved biological products. This statistic shows the share of consumption of biosimilar drugs in Italy from 2016 to 2022.